[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.5.76. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Evidence-Based Dermatology: Research Commentary
March 2009

Alitretinoin as a Potential Advance in the Management of Severe Chronic Hand Eczema

Author Affiliations
 

MICHAELBIGBYMD

 

DAMIANOABENIMD, MPHROSAMARIACORONADSc, MDURBÀGONZÁLEZMD, PhDABRAR AQURESHIMD, MPHHYWELWILLIAMSMSc, PhD, FRCP

Arch Dermatol. 2009;145(3):314-315. doi:10.1001/archdermatol.2008.608

Commentary on: Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial

Ruzicka T, Lynde CW, Jemec GB, et al

Br J Dermatol. 2008;158(4):808-817

Question: Is oral alitretinoin, at a dose of 10 or 30 mg once daily, an effective and safe treatment for severe chronic hand eczema (CHE) refractory to topical corticosteroids?

First Page Preview View Large
First page PDF preview
First page PDF preview
×